T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate

We are T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate CAS:124655-09-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate
CAS.NO:124655-09-0
Synonyms:T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate
(4R-Cis)-6-Hydroxymethyl-2,2-Dimethyl-1,3-Dioxane-4-Acetic Acid 1,1-Dimethylethyl Ester
2-Methyl-2-propanyl 2,4-dideoxy-3,5-O-isopropylidene-D-erythro-hexonate
1,1-Dimethylethyl 2,4-dideoxy-3,5-O-(1-methylethylidene)-D-erythro-hexonoate
(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester
2-[(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic Acid tert-Butyl Ester
tert-Butyl 2,4-dideoxy-3,5-O-isopropylidene-D-erythro-hexonate
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 330.9±17.0 °C at 760 mmHg
Molecular Formula C13H24O5
Molecular Weight 260.327
Flash Point 113.1±14.4 °C
Vapour Pressure 0.0±1.6 mmHg at 25°C
Index of Refraction 1.442
 
Specification:
Appearance:Yellow to brown oil liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rosuvastatin calcium(CAS:147098-20-2).

T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate


Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.4-Fluorobenzoyl chloride CAS:403-43-0 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.(R) -5-Bromo-3 – [(1-metil-2-pirrolidinil) metil] -1H-indol CAS:143322-57-0 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.22128-62-7 China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.

Related Products
Product Name
1-BROMO-4-FLUORO-2-NITROBENZENE View Details
2-Chloro-3-fluoro-5-nitropyridine View Details
L-Lysine Monohydrochloride View Details
L-Alanine manufacturer 2-(dimethylamino)-5,6-dimethylpyrimidin-4-ol manufacturer 3,4-Difluorobenzonitrile manufacturer 4-Bromochlorobenzene manufacturer 2,2,3,3-tetramethylcyclopropanecarboxylic acid manufacturer